Kasumi-3 In Vitro Tumor Cell Target Expression Assay

This assay is to provide Kasumi-3-based In Vitro Tumor Cell Target Expression Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.

Kasumi-3

Human

The cell line was established from the blast cells of a myeloperoxidase-negative acute leukemia patient.
Treatment with either interleukin (IL)-2, IL-3, IL-4, granulocyte-macrophage colony-stimulating factor (GMCSF) or stem cell factor induced the proliferation, characteristic of undifferentiated leukemia.

Acute Myeloblastic Leukemia; AML

Oncology

In Vitro Tumor Cell Target Expression Assay

Kasumi-3-cell based In Vitro Tumor Cell Target Expression Assay

Tumor Marker Expression Assay; Inhibitory Ligand Expression Assay

Tumor Cell Analysis Assay

Use FACS technology to analyze the tumor expression markers.